Brand-heavy companies such as Mankind Pharma, Sun Pharma, Torrent Pharmaceuticals and Eris Lifesciences are expected to ...

How will India’s leading drugmaker handle legal setbacks, volatile market trends, and competition in generics and specialty products?

Shares in Sun Pharma fell sharply after the NSE ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...

The Q2 results season is coming to an end; the entire month of October was packed with giants from every sector declaring ...

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has ...

Sun Pharmaceutical Industries Limited including its subsidiaries ... It includes generics branded generics complex or difficult to make technology intensive products over-the-counter (OTC) products ...

Sun Pharma Advanced Research Company Ltd. key Products/Revenue Segments include Sale of services for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a ...

India’s top drugmaker, Sun Pharma, is working on developing the GLP-1 category ... Natco and Mylan have also collaborated on ...

Seniors have until Dec. 7 to make a decision about their 2025 plans. Help is available to review premiums, deductibles and ...

Products and services Cipla is among India ... The peers of Cipla Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Torrent ...